Eli Lilly And Co (NYSE: LLY) reportedly intends to construct a production plant in western Germany with an estimated investment of €2 billion ($2.17 billion), marking an inaugural substantial production facility in Germany and responding to the increasing pressure to localize critical healthcare manufacturing post-pandemic.
The new site, reportedly situated in Alzey, Germany, is anticipated to generate over 1,000 jobs, including roles in subcontracting and local supply chains. Reuters noted that news conferences have been scheduled in Alzey, where the plant will be built, and in Berlin on ...